Company profilePharmaceutical#297 of 1,318 in Pakistan1 DRAP alert

Sami Pharm (Pvt) Ltd.

Pharmaceutical company · 60 brands · 104 molecules

Ranked #3 of 137 companies in Anti-Infectives

60 registered products 29 pharmaceutical brands 104 distinct molecules 1 DRAP alert

Company overview

registered products

pharmaceutical brands

104

distinct molecules

therapeutic classes

DRAP alerts

Sami Pharm (Pvt) Ltd. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 60 product registrations across 104 distinct molecules. Its portfolio is concentrated in Anti-Infectives and Gastro. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Sami

38 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Anti-Infectives 10

2Suminj1Gm1VialRs 315 2Suminj2Gm1VialRs 420 2Suminj500Mg1S500mgRs 190 Ecasil Dry60Ml 100Mg/5MlRs 498.76 EcasildryRs 560 Ecasildry60mlRs 560 Ecasilinf600mgRs 670 Effifloxinf500mgRs 260 Klintinf500mgRs 78 Mofestinf400mgRs 370

Pain Management 6

AlkeristopicalRs 54 Dicloran Topical30GRs 256.5 DiclorantopicalRs 255 Provas-N Forte650Mg 50MgRs 209 Provasnforte650mgRs 220 ProvasnforteRs 220

Gastro 5

Delanzo DR30mgRs 726.9 Delanzo DR60mgRs 1,035.3 ITP OD150mgRs 541.5 Novotephinf40mgRs 360.01 Xyquil DrRs 95

Diabetes 5

Gpride-M SR1mg 500mgRs 117.1 Gpride-M SR2mg 500mgRs 194.8 Gpridemsr500mgRs 212.1 Gpridemsr1mgRs 117.1 Gpridemsr2mgRs 194.8

Unmapped-Medicine 5

Intig-DRs 156.8 Intig-D60MlRs 256.5 Intigd120mlRs 165 Quadro600mcgRs 450 Quadro300mcgRs 279.9

General 3

LevijonconcenrateforRs 324.28 Levijoninf5mlRs 344.1 Levijoninf10mlRs 257.71

Top molecules by brand count

Paracetamol4 brands

Inf4 brands

Ornithine Aspartate3 brands

Omeprazole2 brands

Linezolid2 brands

Orphenadrine2 brands

Metformin2 brands

Itopride2 brands

Sulbactam2 brands

Cefoperazone2 brands

Therapeutic classes

Conditions treated

Price band (DRAP official ceilings)

Registered products priced by source

DRAP-official43 products · Rs 46.18 – Rs 12,119.44

DVAGO63 products · Rs 35.68 – Rs 3,135

Servaid112 products · Rs 32.33 – Rs 2,730

Median across source: Rs 268.38

Regulatory record

1 alert in the DRAP feed we track.

33. Rapid Alert – SPURIOUS DRUG PRODUCTS (NOVIDAT 500MG Tablets and TONOFLEX-P Tablets)

2026-06-03

Competitive set

Companies whose registered portfolio overlaps most with this one.

Genix Pharma Private Limited44 shared molecules

GETZ PHARMA PAKISTAN (PVT) LTD.42 shared molecules

Barrett Hodgson Pakistan (Private) Ltd.39 shared molecules

SHAIGAN PHARMACEUTICALS (PVT) LTD.37 shared molecules

SAFFRON PHARMACEUTICAL COMPANY37 shared molecules

BOSCH PHARMACEUTICALS (PVT) LTD.37 shared molecules

MACTER INTERNATIONAL (PVT) LTD.34 shared molecules

AGP (PRIVATE) LTD.34 shared molecules

Horizon Pharmaceuticals (Pvt) Limited34 shared molecules

SEARLE PAKISTAN (PVT.) LTD.34 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Genix Pharma Private Limited holds 143 molecules not in this portfolio

GETZ PHARMA PAKISTAN (PVT) LTD. holds 260 molecules not in this portfolio

Barrett Hodgson Pakistan (Private) Ltd. holds 161 molecules not in this portfolio

Get the full profile for Sami

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included